// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























7277 Abstracts

Initial circulating tumor cell count and venous thrombosis-free interval in the course of metastatic breast cancer

Beinse G - San Antonio Breast Cancer Symposium (SABCS) , 2015

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Cosecretion of Cortisol and Estrogen By a Feminizing Adrenocortical Carcinoma

Mongkontida Umphonsathien - Endocrine Society (ENDO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Alora

Abdominal, Thoracic and Cranial Aneursyms in Patients with Acromegaly

Selcuk Dagdelen - Endocrine Society (ENDO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Multi-Comorbidity Is Prevalent in Acromegaly Prior to Its Diagnosis: A Population-Based Study from Denmark

Jakob Dal - Endocrine Society (ENDO) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

The role of thrombus aspiration for primary angioplasty in patients >75 years with ST elevated myocardial infarction: the ESTROFA-MI-elderly study

De La Torre Hernandez J.M - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

ST elevation myocardial infarction in the elderly (>75 yrs): is PPCI for all ages?

Gifford J - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Preliminary experience with drug-coated balloon angioplasty as primary therapy in primary PCI for STEMI

Ho H.H - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Venous thrombosis

N/A

First-in-man (FIM) evaluation of a novel balloon delivery system for the self- apposing coronary artery stent: 30-day results

Lu H - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Clinical characteristics and 12-month outcomes of patients treated with warfarin undergoing PCI

Yazji K - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Warfarin

Early healing after treatment of coronary lesions by everolimus or biolimus-eluting bioresorbable polymer stents: one-month results in the SORT-OUT VIII optical coherence tomography study

Riise Balleby I - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

Umirolimus

A new novolimus-eluting bioresorbable scaffold with a strut thickness of 100 m, first clinical experience: an OCT evaluation in an all-comers population

Nef H - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Short- and midterm outcomes of PCI with bioresorbable vascular scaffolds for STEMI treatment

Khripun A - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Prognosis is similar for STEMI patients treated with primary PCI during office hours and during off-hours: a report from SCAAR

Omerovic E - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Efficacy and safety of left atrial appendage occlusion with the watchman device without post-procedure oral anticoagulation

Spina R - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Warfarin

Safety and efficacy of carotid stenting in the treatment of carotid artery stenosis: immediate results and long-term follow-up in our experience

Moncalvo C - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

N/A

Effect on clinical outcomes of short- or long-duration dual antiplatelet therapy after drug-eluting stents: a meta-analysis of randomised trials

Ferrante G - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Duration of dual antiplatelet therapy following drug-eluting stent implantation: a systematic review and meta-analysis of randomised controlled trials

Giustino G - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Risk and benefits of a triple antithrombotic regimen in patients undergoing percutaneous coronary stent implantation requiring chronic oral anticoagulation: a meta-analysis of 12 trials

Barbieri L - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

The optimal duration of dual antiplatelet therapy after drug-eluting stent: a risk-benefit analysis using Bayesian Network meta-analysis of randomised controlled trials

Sethi A - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

In-hospital and long-term outcomes of mesh covered MGUARD stent implantation for treatment of ST-segment elevation myocardial infarction with high thrombus burden despite manual aspiration

Cerrato E - European Association of Percutaneous Cardiovascular Intervention (EuroPCR) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Copyright © 2026. QuantiNova All rights reserved